New cyclo (d)-fused bicyclic azepane derivatives, are selective farnesyl transferase inhibitors useful for treating cancer diseases, restenosis or type I neurofibromatosis

    公开(公告)号:FR2819512A1

    公开(公告)日:2002-07-19

    申请号:FR0100639

    申请日:2001-01-18

    Applicant: SERVIER LAB

    Abstract: N-Substituted cyclo (d)-fused bicyclic azepane or azepanone derivatives (I) are new. Bicyclic azepane derivatives of formula (I) and their enantiomers, diastereomers and acid or base addition salts are new. W = CO or CH2; X = direct bond, alkylene, CO, S(O)n, S(O)n-A1, CO-A1, A1-S(O)n-A1 or A1-CO-A1 (bonded to the ring at the left-hand terminal); A1 = alkylene; n = 0-2; Y = aryl, heteroaryl, cycloalkyl or heterocycloalkyl (all optionally substituted (os) by R6); R1, R2 = H or as for Y; or together form a bond; T = CHR3, NR3 or NR3CO (bonded to the ring at the left-hand terminal); R3 = H; or alkyl, aryl, heteroaryl, aralkyl or heteroaralkyl (all os by one or more R5); V = H; or aryl or heteroaryl (both os by one or more R5); A2 = -(CR4R'4)p; p = 0-4 (but not 0 if T = NR3); R4, R'4 = H, alkyl (os by R7), alkenyl, alkynyl or R7; R7 = OR3, NR3R'3, S(O)nR3, CONR3R'3, NR3COR'3, NR3SO2R'3, SO2NR3R'3 or NR3COOR'3; R'3 = as R3; R5 = halo, alkyl, alkoxy, OH, SH, alkylthio, CN, NH2 (os by 1 or 2 alkyl), NO2, COOH, alkoxycarbonyl, CONH2 (os by 1 or 2 alkyl), carbamoyl, os aryl, os aralkyl, os heteroaryl, os heteroaralkyl, os cycloalkyl, os cycloalkylalkyl, os heterocycloalkyl or os heterocycloalkylalkyl; R6 = halo, =O, OH, CN, NO2, COOH, alkoxycarbonyl, U-R60 or A60-U-R60; A60 = alkylene; U = direct bond, O, NH, S(O)n, NHCO, CONH, SO2NH or NHSO2; R60 = alkyl, aryl, aralkyl, heteroaryl or heteroarylalkyl; B' = group completing an optionally partially hydrogenated aryl or heteroaryl group (os by one or more of CN, alkyl, alkoxy, OH or halo); alkyl or alkylene moieties have 1-6C; cycloalkyl moieties have 3-8C; heterocycloalkyl moieties are 5-7 membered and contain 1-3 of N, O and S as heteroatom(s); aryl moieties are phenyl or naphthyl; heteroaryl moieties are mono- or bicyclic 5-11 membered systems containing at least one aromatic ring and 1-5 of N, O and S as heteroatom(s); the substituents in os aryl, heteroaryl, aralkyl or heteroaralkyl are one or more of CN, alkylcarbonyl, CONH2 (os by 1 or 2 alkyl) or halo (in the ring part); the substituents in os cycloalkyl, heterocycloalkyl, cycloalkylalkyl or heterocycloalkylalkyl are one or more of =O, CN, alkylcarbonyl, CONH2 (os by 1 or 2 alkyl) or halo (in the ring part). An Independent claim is included for the preparation of (I).

    НОВЫЕ СОЕДИНЕНИЯ ДИГИДРО- И ТЕТРАГИДРОХИНОЛИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ СОСТАВЫ

    公开(公告)号:EA199900865A3

    公开(公告)日:2000-10-30

    申请号:EA199900865

    申请日:1999-10-22

    Applicant: SERVIER LAB

    Abstract: Соединениеобщейформулы (I)где Rпредставляетсобойатомводородаилигруппугде A являетсятаким, какопределенов описании,Rи R, каждыйнезависимо, представляютсобойалкил, циклоалкил, гетероциклоалкил, необязательнозамещенныйарил, необязательнозамещенныйгетероарил, циклоалкилалкил, гетероциклоалкилалкил, необязательнозамещенныйарилалкил, необязательнозамещенныйгетероарилалкилилинеобязательнозамещенныйаминоалкилилиRи Rвместесосвязывающимихатомомуглеродаобразуютциклоалкильнуюилимоноциклическуюгетероциклическуюгруппу, замещеннуюилинезамещенную,Rпредставляетсобойатомводородаилигруппу, выбраннуюизнеобязательнозамещенногоалкила, необязательнозамещенногоалкенилаи необязательнозамещенногоалкинила, илигруппу Q или - V-Q-, где V представляетсобойгруппуалкилена, алкениленаилиалкиниленаи Q представляетсобойнеобязательнозамещеннуюциклоалкильнуюгруппу, необязательнозамещеннуюарильнуюгруппу, необязательнозамещеннуюгетероциклоалкильнуюгруппуилинеобязательнозамещеннуюгетероарильнуюгруппу,Rи Rобразуютвместесвязьиликаждыйпредставляетсобойатомводорода,R, R, Rи Rкаждыйнезависимопредставляетсобойатомводорода, атомгалогена, алкильнуюгруппу, (C-C)циклоалкильнуюгруппуилигруппу -OW, где W являетсятаким, какопределенов описании.

    24.
    发明专利
    未知

    公开(公告)号:PT995743E

    公开(公告)日:2003-07-31

    申请号:PT99402624

    申请日:1999-10-22

    Applicant: SERVIER LAB

    Abstract: Dihydro- and tetrahydro-quinoline derivatives (I) are new. Dihydro- and tetrahydro-quinoline derivatives of formula (I) and their acid or base addition salts are new. R1 = H or a group of formula (i); A = H or -B'NZ1Z2; B' = 1-6C alkylene; Z1, Z2 = H, alkyl, 3-8C cycloalkyl or optionally substituted aryl; or NZ1Z2 = heterocycloalkyl or heteroaryl (optionally substituted); R2, R3 = alkyl, 3-8C cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl or aminoalkyl (optionally substituted on N with 1 or 2 alkyl, cycloalkyl, aryl or arylalkyl); or R2 + R3 = form with C of quinoline, 3-8C cycloalkyl or heterocycloalkyl (optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl); R40 = alkyl, 2-6C alkenyl, 2-6C alkynyl (all optionally substituted), H, Q or -V'-Q; V' = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; Q = 3-8C cycloalkyl, aryl, heterocycloalkyl, heteroaryl (all optionally substituted); R5, R41 = H; or R5 + R41 = bond; R6-R9 = H, halo, alkyl, 3-8C cycloalkyl or -OW'; W' = aryl, heteroaryl, arylalkyl, heteroarylalkyl (all optionally substituted), H, alkyl, acyl, 3-8C cycloalkyl or heterocycloalkyl; alkyl = 1-6C; aryl = phenyl, naphthyl or biphenyl; heterocycloalkyl = partially unsaturated 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; heteroaryl = aromatic or partially aromatic 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; substituted aryl, arylalkyl = aryl or arylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted by 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro or OH; substituted alkyl, alkenyl, alkynyl and cycloalkyl = alkyl, alkenyl, alkynyl and cycloalkyl substituted with at least one OH, 1-6C alkoxy, 1-6C alkylthio, amino (optionally substituted with 1 or 2 alkyl), carboxy, nitro, CN, 1-6C alkoxycarbonyl or aminocarbonyl (optionally substituted with 1 or 2 alkyl on N); substituted heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl = heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted with 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro, OH or oxo; and provided that R6-R9 are not all H and at least one of R6-R9 is -OW', that R2 and R3 are alkyl when R6-R9 are H, alkyl, alkoxy, R41 and R5 form a bond, R40 is other than H or alkyl; when (I) has one OH and R40 is other than H; when (I) has one methoxy and R40 is other than hydroxyalkyl; and (I) is other than 7-methoxy-2,2-diphenyl-1,2-dihydroquinoline. An Independent claim is also included for the preparation of (I).

    Cycloheptene derivatives and pharmaceuticals thereof

    公开(公告)号:NZ516684A

    公开(公告)日:2003-06-30

    申请号:NZ51668402

    申请日:2002-01-17

    Applicant: SERVIER LAB

    Abstract: Compounds of formula (I); where: X is a bond, alkylene, CO, S(O)n, *-S(O)n-A1-, *-CO-A1-, -A1-S(O)n-A'1- or -A1-CO-A'1 (where A1 and A'1 independently represent an alkylene group, and n is 0, 1 or 2), the symbol "*" indicating the point of attachment of those groups to the cycloheptene; Y is an optionally substituted aryl, heteroaryl, cycloalkyl or heterocycloalkyl group; R1, R2, R3 and R4 are independently hydrogen, or optionally substituted aryl, heteroaryl, cycloalkyl or heterocycloalkyl; or R1 and R2, or R2 and R3, or R3 and R4, taken in pairs, together form a bond; or R1 and R2, or R2 and R3, or R3 and R4, taken in pairs with the carbon atoms to which they are bonded, form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle, having 5 or 6 ring members and containing 1 or 2 heteroatoms selected from nitrogen, oxygen and sulfur, on the understanding that only one ring can be fused on the 7-membered structure; T is ?H(R5)-, -N(R5)- or *-N(R5)CO- (where R5 is a hydrogen atom or is an optionally substituted alkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl group) , the symbol "*" indicating the point of attachment of this group to the cycloheptene; V is hydrogen or is an optionally substituted aryl or heteroaryl group; A2 is a [C(R6)(R'6)]p group where p is 0, 1, 2, 3 or 4 when T represents a -CH(R5)- or *-N(R5)CO- group, or p is 1, 2, 3 or 4 when T represents an -N(R5)- group. Pharmaceutical compositions comprising the compound of formula (I) are also described.

    26.
    发明专利
    未知

    公开(公告)号:DE69906445D1

    公开(公告)日:2003-05-08

    申请号:DE69906445

    申请日:1999-10-22

    Applicant: SERVIER LAB

    Abstract: Dihydro- and tetrahydro-quinoline derivatives (I) are new. Dihydro- and tetrahydro-quinoline derivatives of formula (I) and their acid or base addition salts are new. R1 = H or a group of formula (i); A = H or -B'NZ1Z2; B' = 1-6C alkylene; Z1, Z2 = H, alkyl, 3-8C cycloalkyl or optionally substituted aryl; or NZ1Z2 = heterocycloalkyl or heteroaryl (optionally substituted); R2, R3 = alkyl, 3-8C cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl or aminoalkyl (optionally substituted on N with 1 or 2 alkyl, cycloalkyl, aryl or arylalkyl); or R2 + R3 = form with C of quinoline, 3-8C cycloalkyl or heterocycloalkyl (optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl); R40 = alkyl, 2-6C alkenyl, 2-6C alkynyl (all optionally substituted), H, Q or -V'-Q; V' = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; Q = 3-8C cycloalkyl, aryl, heterocycloalkyl, heteroaryl (all optionally substituted); R5, R41 = H; or R5 + R41 = bond; R6-R9 = H, halo, alkyl, 3-8C cycloalkyl or -OW'; W' = aryl, heteroaryl, arylalkyl, heteroarylalkyl (all optionally substituted), H, alkyl, acyl, 3-8C cycloalkyl or heterocycloalkyl; alkyl = 1-6C; aryl = phenyl, naphthyl or biphenyl; heterocycloalkyl = partially unsaturated 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; heteroaryl = aromatic or partially aromatic 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; substituted aryl, arylalkyl = aryl or arylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted by 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro or OH; substituted alkyl, alkenyl, alkynyl and cycloalkyl = alkyl, alkenyl, alkynyl and cycloalkyl substituted with at least one OH, 1-6C alkoxy, 1-6C alkylthio, amino (optionally substituted with 1 or 2 alkyl), carboxy, nitro, CN, 1-6C alkoxycarbonyl or aminocarbonyl (optionally substituted with 1 or 2 alkyl on N); substituted heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl = heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted with 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro, OH or oxo; and provided that R6-R9 are not all H and at least one of R6-R9 is -OW', that R2 and R3 are alkyl when R6-R9 are H, alkyl, alkoxy, R41 and R5 form a bond, R40 is other than H or alkyl; when (I) has one OH and R40 is other than H; when (I) has one methoxy and R40 is other than hydroxyalkyl; and (I) is other than 7-methoxy-2,2-diphenyl-1,2-dihydroquinoline. An Independent claim is also included for the preparation of (I).

    НОВЫЕ СОЕДИНЕНИЯ ДИГИДРО- И ТЕТРАГИДРОХИНОЛИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ СОСТАВЫ

    公开(公告)号:EA199900865A2

    公开(公告)日:2000-04-24

    申请号:EA199900865

    申请日:1999-10-22

    Applicant: SERVIER LAB

    Abstract: Соединениеобщейформулы (I)где Rпредставляетсобойатомводородаилигруппугде A являетсятаким, какопределенов описании,Rи R, каждыйнезависимо, представляютсобойалкил, циклоалкил, гетероциклоалкил, необязательнозамещенныйарил, необязательнозамещенныйгетероарил, циклоалкилалкил, гетероциклоалкилалкил, необязательнозамещенныйарилалкил, необязательнозамещенныйгетероарилалкилилинеобязательнозамещенныйаминоалкилилиRи Rвместесосвязывающимихатомомуглеродаобразуютциклоалкильнуюилимоноциклическуюгетероциклическуюгруппу, замещеннуюилинезамещенную,Rпредставляетсобойатомводородаилигруппу, выбраннуюизнеобязательнозамещенногоалкила, необязательнозамещенногоалкенилаи необязательнозамещенногоалкинила, илигруппу Q или - V-Q-, где V представляетсобойгруппуалкилена, алкениленаилиалкиниленаи Q представляетсобойнеобязательнозамещеннуюциклоалкильнуюгруппу, необязательнозамещеннуюарильнуюгруппу, необязательнозамещеннуюгетероциклоалкильнуюгруппуилинеобязательнозамещеннуюгетероарильнуюгруппу,Rи Rобразуютвместесвязьиликаждыйпредставляетсобойатомводорода,R, R, Rи Rкаждыйнезависимопредставляетсобойатомводорода, атомгалогена, алкильнуюгруппу, (C-C)циклоалкильнуюгруппуилигруппу -OW, где W являетсятаким, какопределенов описании.

Patent Agency Ranking